Pharma Companies Without Comment on Russian Market Future
Pharma companies didn’t want to comment effects of the sanctions against Russia.
Pharmaceuticals, Biotechnology and Life Sciences
Pharma companies didn’t want to comment effects of the sanctions against Russia.
In the pharmaceutical industry, the issue of sustainability is increasingly coming into focus, forcing packaging manufacturers to rethink their strategies…
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing…
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling…
The European Commission (EC) approved Sanofi’s Sarclisa (isatuximab) in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with relapsed multiple myeloma who have received at least one prior therapy.…
AstraZeneca’s Tagrisso has been approved in China for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor…
U.S. CDC and FDA called for a pause in the J&J’s vaccine use following the emergence of a rare blood clotting disorder in six recipients.
Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small…
Bayer announced results from the randomized, double-blind, placebo-controlled Phase III trial CHRONOS-3 show a significant progression-free survival (PFS) benefit for…
Sanofi has acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel mRNA-based approach for in vivo reprogramming…